跳至主要内容
临床试验/NL-OMON41356
NL-OMON41356已完成不适用

Effect of Carbon Dioxide Enriched Ambient Air on Pharmacokinetics and Deposition In Bronchiectasis Patients Using Tobramycin Inhalation: A proof of concept study. - Effect of CO2 on Deposition and Pharmacokinetics of Nebulized Tobramycin

Vrije Universiteit Medisch Centrum0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • o Bronchiectasis.
  • o Antibiotic inhalation therapy

排除标准

  • o Age <21 years.
  • o Chronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
  • o Renal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
  • o Neuromuscular diseases.
  • o Impaired hearing
  • o Pregnant or breastfeeding.
  • o Bronchiectasis exacerbation during last 4 weeks.
  • o History of panic attacks.

研究者

相似试验